De Brabander; Jef K.
Patent Applications and Registrations
Patent applications and USPTO patent grants for De Brabander; Jef K..The latest application filed is for "therapeutics targeting mutant adenomatous polyposis coli (apc) for the treatment of cancer".
Company Profile
1.28.28
- De Brabander; Jef K. - Austin TX
- De Brabander; Jef K. - Flower Mound TX
- De Brabander; Jef K. - Dallas TX
- De Brabander; Jef K. - Lewisville TX
Patent Activity
| Patent | Date |
|---|---|
| Therapeutics Targeting Mutant Adenomatous Polyposis Coli (apc) For The Treatment Of Cancer App 20220024891 - De Brabander; Jef K. ; et al. | 2022-01-27 |
| Anti-depression compounds Grant 10,183,011 - McKnight , et al. Ja | 2019-01-22 |
| Pro-neurogenic compounds Grant 10,172,827 - McKnight , et al. J | 2019-01-08 |
| Pro-Neurogenic Compounds App 20180318255 - McKnight; Steven L. ; et al. | 2018-11-08 |
| Pro-Neurogenic Compounds App 20180127367 - McKnight; Steven L. ; et al. | 2018-05-10 |
| Pro-neurogenic compounds Grant 9,962,368 - McKnight , et al. May 8, 2 | 2018-05-08 |
| Pro-neurogenic compounds Grant 9,884,820 - McKnight , et al. February 6, 2 | 2018-02-06 |
| Anti-depression Compounds App 20170157092 - McKnight; Steven L. ; et al. | 2017-06-08 |
| Anti-depression compounds Grant 9,616,048 - McKnight , et al. April 11, 2 | 2017-04-11 |
| Pro-neurogenic Compounds App 20160362372 - McKnight; Steven L. ; et al. | 2016-12-15 |
| Pro-Neurogenic Compounds App 20160362373 - McKnight; Steven L. ; et al. | 2016-12-15 |
| Pro-neurogenic compounds Grant 9,446,022 - McKnight , et al. September 20, 2 | 2016-09-20 |
| Pro-neurogenic compounds Grant 9,446,042 - McKnight , et al. September 20, 2 | 2016-09-20 |
| Anti-depression Compounds App 20160206596 - McKnight; Steven L. ; et al. | 2016-07-21 |
| Pro-Neurogenic Compounds App 20160206594 - McKnight; Steven L. ; et al. | 2016-07-21 |
| Pro-neurogenic Compounds App 20160074361 - McKnight; Steven L. ; et al. | 2016-03-17 |
| Pro-neurogenic compounds Grant 9,278,923 - McKnight , et al. March 8, 2 | 2016-03-08 |
| Anti-depression compounds Grant 9,162,980 - McKnight , et al. October 20, 2 | 2015-10-20 |
| Pro-neurogenic Compounds App 20150290195 - McKnight; Steven L. ; et al. | 2015-10-15 |
| Pro-neurogenic compounds Grant 9,156,787 - McKnight , et al. October 13, 2 | 2015-10-13 |
| Pro-neurogenic compounds Grant 9,095,571 - McKnight , et al. August 4, 2 | 2015-08-04 |
| Pro-neurogenic compounds Grant 9,095,572 - McKnight , et al. August 4, 2 | 2015-08-04 |
| Pro-Neurogenic Compounds App 20150057301 - McKnight; Steven L. ; et al. | 2015-02-26 |
| Anti-depression Compounds App 20140343018 - McKnight; Steven L. ; et al. | 2014-11-20 |
| Methods for treating Parkinson's disease using pro-neurogenic compounds Grant 8,877,797 - McKnight , et al. November 4, 2 | 2014-11-04 |
| Methods of treating traumatic brain injury using pro-neurogenic compounds Grant 8,791,149 - McKnight , et al. July 29, 2 | 2014-07-29 |
| Methods of treating post-traumatic stress disorder using pro-neurogenic compounds Grant 8,748,473 - McKnight , et al. June 10, 2 | 2014-06-10 |
| Methods for treating amyotrophic lateral sclerosis using pro-neurogenic compounds Grant 8,735,440 - McKnight , et al. May 27, 2 | 2014-05-27 |
| Pro-Neurogenic Compounds App 20140094480 - McKnight; Steven L. ; et al. | 2014-04-03 |
| Pro-neurogenic compounds Grant 8,604,074 - McKnight , et al. December 10, 2 | 2013-12-10 |
| Pro-Neurogenic Compounds App 20130190339 - McKnight; Steven L. ; et al. | 2013-07-25 |
| Methods for Treating Amyotrophic Lateral Sclerosis Using Pro-Neurogenic Compounds App 20130190273 - McKnight; Steven L. ; et al. | 2013-07-25 |
| Methods of Treating Post-Traumatic Stress Disorder Using Pro-Neurogenic Compounds App 20130184301 - McKnight; Steven L. ; et al. | 2013-07-18 |
| Methods of Treating Traumatic Brain Injury Using Pro-Neurogenic Compounds App 20130184300 - McKnight; Steven L. ; et al. | 2013-07-18 |
| Methods for Treating Parkinson's Disease Using Pro-Neurogenic Compounds App 20130184271 - McKnight; Steven L. ; et al. | 2013-07-18 |
| Pro-Neurogenic Compounds App 20130040977 - McKnight; Steven L. ; et al. | 2013-02-14 |
| Pro-neurogenic compounds Grant 8,362,277 - McKnight , et al. January 29, 2 | 2013-01-29 |
| Dimeric small molecule potentiators of apoptosis Grant 8,143,418 - Harran , et al. March 27, 2 | 2012-03-27 |
| Pro-neurogenic Compounds App 20120022096 - McKnight; Steven L. ; et al. | 2012-01-26 |
| Dimeric Small Molecule Potentiators of Apoptosis App 20110124585 - Harran; Patrick G. ; et al. | 2011-05-26 |
| Dimeric small molecule potentiators of apoptosis Grant 7,884,211 - Harran , et al. February 8, 2 | 2011-02-08 |
| Pro-Neurogenic Compounds App 20110015217 - MCKNIGHT; STEVEN L. ; et al. | 2011-01-20 |
| Pro-Neurogenic Compounds App 20110003836 - McKnight; Steven L. ; et al. | 2011-01-06 |
| Palmerolides: methods of preparation and derivatives thereof Grant 7,838,691 - De Brabander , et al. November 23, 2 | 2010-11-23 |
| Dimeric small molecule potentiators of apoptosis Grant 7,816,538 - Harran , et al. October 19, 2 | 2010-10-19 |
| Dimeric small molecule potentiators of apoptosis Grant 7,638,544 - Harran , et al. December 29, 2 | 2009-12-29 |
| Dimeric Small Molecule Potentiators of Apoptosis App 20090281155 - Harran; Patrick G. ; et al. | 2009-11-12 |
| Palmerolides: Methods Of Preparation And Derivatives Thereof App 20080249162 - DE BRABANDER; Jef K. ; et al. | 2008-10-09 |
| Dimeric Small Molecule Potentiators of Apoptosis App 20080119532 - Harran; Patrick G. ; et al. | 2008-05-22 |
| Dimeric small molecule potentiators of apoptosis Grant 7,309,792 - Harran , et al. December 18, 2 | 2007-12-18 |
| Dimeric small molecule potentiators of apoptosis App 20050197403 - Harran, Patrick G. ; et al. | 2005-09-08 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 